# NELARABINE
> **ANDA215037** · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2021-11-17
## Drug
- **FDA Application Number:** ANDA215037
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NELARABINE
- **Generic name:** NELARABINE
- **Active ingredients:** NELARABINE
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** ZYDUS PHARMS
- **Manufacturer:** Zydus Lifesciences Limited
- **First approval:** 2021-11-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215037)
---
*MORVS · CC0 1.0*